A multi-gene expression profile panel for predicting liver metastasis: An algorithmic approach

Area of Science:

• Oncology
• Molecular Diagnostics
• Cancer Genomics

Background:

• Liver metastasis significantly impacts outcomes in several cancers, but its role in lung cancer remains unclear.
• Lung cancer patients have a low 5-year survival rate due to therapy resistance linked to genetic factors.
• Early diagnosis and treatment of liver metastasis in lung cancer are critical for improving patient prognosis.

Purpose of the Study:

• To develop a predictive model for the early diagnosis of liver metastasis in lung cancer.
• To identify key genetic modulators involved in the pathogenesis of liver metastasis in lung cancer.
• To enable timely treatment strategies for lung cancer patients with liver metastasis.

Main Methods:

• Quantified mRNA expression of 15 genes in lung cancer specimens with and without liver metastasis using real-time PCR.
• Employed Principal Component Analysis (PCA), Linear Discriminant Analysis (LDA), and hierarchical clustering to generate predictive models.
• Validated model accuracy using Receiver Operating Curve (ROC) analysis.

Main Results:

• Five predictive models were generated using PCA and LDA; ROC analysis identified 8 genes with significant sensitivity and specificity.
• A multi-gene panel of 8 selected genes achieved 90.0% specificity and 96.87% sensitivity (p <0.0001).
• Hierarchical clustering indicated a correlation between higher fold change in tumors and poorer prognosis.

Conclusions:

• A concise, biologically relevant multi-gene panel was developed to predict liver metastasis in lung cancer.
• The panel offers a significant, non-invasive method for early detection of liver metastasis.
• This advancement facilitates timely therapeutic interventions, potentially improving survival rates for lung cancer patients.